AtaiBeckley Inc.

AtaiBeckley Inc.

Organization

Heard in 7 episodes across 4 shows since Jul 2026

AtaiBeckley Inc. is a clinical-stage biotechnology company focused on developing rapid-acting and convenient treatments for mental health disorders. Formed in late 2025 through the merger of atai Life Sciences and Beckley Psytech, the company researches and develops innovative therapies, including those based on psychedelics and entactogens.

Episodes

7
across 4 shows

First heard

Jul 2026

Expert statements

1
1 negative

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20263
Aug 20261
Sep 20261
Oct 20261
Nov 20261

Email alert

Email me when AtaiBeckley Inc. comes up on a podcast

One email a week at most, with the new episodes that mention AtaiBeckley Inc.. Free, no account needed, unsubscribe in one click.

What experts have said about AtaiBeckley Inc.

1 statement · 1 negative

  1. Jim CramerNegativeSep 2, 2026· Mad Money w/ Jim Cramer

    Cramer sees limited upside in ATAI because of its merger with Eli Lilly.

    “That one's merging with Lilly, so I'm not sure there's a lot of upside.”

    Listen at 45:16

    Open the episode · Mad Money w/ Jim Cramer 9/2/26

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

7 episodes featuring AtaiBeckley Inc., newest first